US Broker Ratings

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: A 330% Upside Potential Beckons Investors

Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to mRNA cell therapies. Specializing in treatments for autoimmune diseases,..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 201% Potential Upside in the Medical Tech Sector

Investors eyeing the healthcare sector may find Nyxoah SA (NASDAQ: NYXH) an intriguing opportunity, particularly given its substantial potential upside of over 201% as projected by analysts. Based in Belgium,..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Potential 143.90% Upside

Investors eyeing the biotechnology sector may find Fulcrum Therapeutics, Inc. (NASDAQ: FULC) an intriguing opportunity. With a market capitalization of $518.82 million, this clinical-stage biopharmaceutical company is committed to advancing..

Canopy Growth Corporation (CGC): Investor Outlook and Potential 68.89% Upside

Canopy Growth Corporation (NYSE: CGC), a pivotal player in the evolving cannabis sector, offers intriguing prospects for investors seeking exposure in the healthcare industry. With its deep-rooted operations in the..

Entrada Therapeutics, Inc. (TRDA): Analyst Consensus Points to 48% Upside Potential in Biotech

For investors with an eye on the biotechnology sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a compelling opportunity. With a market capitalization of $516.84 million, Entrada operates within the healthcare..

Zhengye Biotechnology Holding L (ZYBT): Exploring the Growth Potential Amidst Market Volatility

Zhengye Biotechnology Holding L (ZYBT), a Chinese company specialized in veterinary vaccines, stands at a critical juncture for investors seeking opportunities within the healthcare sector. With a market capitalization of..

Absci Corporation (ABSI) Stock Analysis: Exploring a 228% Potential Upside in Biotechnology

Absci Corporation (NASDAQ: ABSI) has emerged as a unique player in the biotechnology sector, leveraging cutting-edge artificial intelligence (AI) to revolutionize drug creation. With a market capitalization of $368.41 million,..

TotalEnergies SE (TTE) Stock Analysis: Navigating a Complex Energy Landscape with a Robust Dividend Yield

TotalEnergies SE (TTE), a leading player in the energy sector, is capturing investor attention with its dynamic approach to the integrated oil and gas industry. Headquartered in Courbevoie, France, TotalEnergies..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 96.80% Upside Potential Amid Innovative Genetic Therapies

Benitec Biopharma Inc. (BNTC), a prominent player in the biotechnology sector, is capturing investor attention with its focus on developing groundbreaking genetic medicines. Headquartered in Hayward, California, this clinical-stage biotechnology..

Chevron Corporation (CVX) Stock Analysis: Navigating Growth and Value in the Energy Sector

As Chevron Corporation (NYSE: CVX) continues to assert its position as a leader in the integrated oil and gas industry, individual investors are keenly observing its financial metrics and market..

Exxon Mobil Corporation (XOM) Stock Analysis: Evaluating the Energy Giant Amid Market Volatility

Exxon Mobil Corporation (NYSE: XOM), a stalwart in the energy sector and one of the world’s largest publicly traded companies, continues to be a focal point for investors looking to..

MiMedx Group, Inc. (MDXG) Investor Outlook: A High Potential Upside of 114% Beckons

MiMedx Group, Inc. (NASDAQ: MDXG) stands as a compelling opportunity for investors with a keen eye on the healthcare sector. Positioned within the biotechnology industry, this U.S.-based company, with a..

Harrow, Inc. (HROW) Stock Analysis: Eye on Nearly 100% Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector should consider Harrow, Inc. (NASDAQ: HROW), a key player in the niche market of ophthalmic pharmaceuticals. With a market capitalization of..

Novavax, Inc. (NVAX) Stock Analysis: Potential 30.6% Upside Amid Strong Revenue Growth

Novavax, Inc. (NVAX), a key player in the biotechnology sector, is drawing attention from investors with its notable revenue growth and potential upside. As a company at the forefront of..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Eyeing a 163% Potential Upside in the Biotech Sector

Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity for investors in the biotechnology sector, with a compelling potential upside of 163.25%. As a company dedicated to developing and commercializing..

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with a 152% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing attention in the healthcare sector with its innovative approach to RNA medicine. With a market..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 179.85% Potential Upside

MannKind Corporation (NASDAQ: MNKD) is a noteworthy player in the biotech sector, focusing on innovative treatments for chronic diseases. With a robust portfolio that includes solutions for diabetes, pulmonary hypertension,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Unveiling a 64% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE) is a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in the United States, this innovative company is..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech with a Potential 92.80% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is a standout player in the biotechnology industry, with its focus on developing oral small molecule therapeutics aimed at treating chronic diseases that have significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds